30 Day Trial

BARE BONES content is posted to these pages in real time.

Monthly compilations are available in PDF form.

Strategic Initiatives

WishBone Medical Gains Distribution Rights to OsteoCrete Bone Void Filler -

WishBone Medical entered into a private label distribution agreement with Bone Solutions for worldwide rights to sell OsteoCrete® bone void filler in pediatric applications. OsteoCrete is the first bone void filler in the U.S. to incorporate magnesium oxide to enhance bone development. It is 100% resorbable and also injectable, moldable and biocompatible, and cleared for use in a range of treatments such as complex sport-related injuries to all musculoskeletal extremities trauma cases. Bone Solutions has surpassed 600 cases implanting OsteoCrete (up from 500 in February 2019), and the company seeks to develop additional bioresorbable implants for further applications with the technology. Bioresorbable implants are of particular benefit in pediatric applications, as they obviate the need for a second procedure to remove a metal implant. (WishBone Medical, 8/15/19)